Standard BioTools Inc. (NasdaqGS:LAB) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its shares. The repurchases are contingent upon favorable market and business conditions and are funded by cash on hand.

The program will run till March 1, 2026.